Results 151 to 160 of about 71,839 (258)

<i>Bacillus velezensis</i> CML532 supplementation improved growth performance, protein digestion, and gut health in broilers fed with corn-miscellaneous meal-based low-protein diets. [PDF]

Anim Nutr
Wang J, Zhang X, Luo C, Wang M, Wang X, Guo Y.   +5 more
europepmc   +1 more source

A bird's-eye view of soil pollution research in the U.S.A. [PDF]

, 1974
Haan, F.A.M., de
core   +1 more source

Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/mTOR and MMP2‐COL3A1 axis

Molecular Oncology, EarlyView.
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak, Iva Staniczková Zambo, Matěj Přikryl, Peter Múdry, Danica Zapletalová, Jarmila Navrátilová, Jiří Navrátil, Jan Šmarda, Liudmyla Drobot, Petr Beneš, Lucia Knopfová   +10 more
wiley   +1 more source

Rethinking asthma therapy, part 2: transdermal strategies for adjunct asthma and allergy treatments. [PDF]

J Pharm Pharm Sci
Correa J, Brogden NK.
europepmc   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Jianzhen's eastward sea-voyage

Journal of Traditional Chinese Medical Sciences, 2023
Yongxuan Liang, Yinghua Huang
doaj   +1 more source

Predictors of outpatient treatment engagement following a visit to a specialized emergency department for substance use: A cohort study using high-resolution electronic health records. [PDF]

Addiction
Romero D, Kåberg M, Berman AH, Carlbring P, Franck J, Lindner P.   +5 more
europepmc   +1 more source

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

Molecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy, Jana Löptien, Cornelia Coith, Afroditi Nanou, Katharina Hintelmann, Pinnschmidt Hans, Cordula Petersen, Klaus Pantel, Sabine Riethdorf, Kerstin Borgmann, Harriet Wikman   +10 more
wiley   +1 more source

Stellate Ganglion Block in the Treatment of Long COVID: A Systematic Review. [PDF]

Curr Pain Headache Rep
Peddireddy S, VanWingerden N, Patel P, Howard G, Berger J.   +4 more
europepmc   +1 more source